285 related articles for article (PubMed ID: 35219661)
1. Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations.
Ravichandran J; Karthikeyan BS; Samal A
Sci Total Environ; 2022 Jun; 826():154112. PubMed ID: 35219661
[TBL] [Abstract][Full Text] [Related]
2. Mapping DEHP to the adverse outcome pathway network for human female reproductive toxicity.
Pogrmic-Majkic K; Samardzija Nenadov D; Tesic B; Fa Nedeljkovic S; Kokai D; Stanic B; Andric N
Arch Toxicol; 2022 Oct; 96(10):2799-2813. PubMed ID: 35790550
[TBL] [Abstract][Full Text] [Related]
3. Semantic characterization of adverse outcome pathways.
Wang RL
Aquat Toxicol; 2020 May; 222():105478. PubMed ID: 32278258
[TBL] [Abstract][Full Text] [Related]
4. An integrative data-centric approach to derivation and characterization of an adverse outcome pathway network for cadmium-induced toxicity.
Sahoo AK; Chivukula N; Ramesh K; Singha J; Marigoudar SR; Sharma KV; Samal A
Sci Total Environ; 2024 Apr; 920():170968. PubMed ID: 38367714
[TBL] [Abstract][Full Text] [Related]
5. A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis.
Verhoeven A; van Ertvelde J; Boeckmans J; Gatzios A; Jover R; Lindeman B; Lopez-Soop G; Rodrigues RM; Rapisarda A; Sanz-Serrano J; Stinckens M; Sepehri S; Teunis M; Vinken M; Jiang J; Vanhaecke T
Toxicology; 2024 Jun; 505():153814. PubMed ID: 38677583
[TBL] [Abstract][Full Text] [Related]
6. Development of an adverse outcome pathway network for nephrotoxicity.
Barnes DA; Firman JW; Belfield SJ; Cronin MTD; Vinken M; Janssen MJ; Masereeuw R
Arch Toxicol; 2024 Mar; 98(3):929-942. PubMed ID: 38197913
[TBL] [Abstract][Full Text] [Related]
7. Linking nanomaterial-induced mitochondrial dysfunction to existing adverse outcome pathways for chemicals.
Murugadoss S; Vinković Vrček I; Schaffert A; Paparella M; Pem B; Sosnowska A; Stępnik M; Martens M; Willighagen EL; Puzyn T; Roxana Cimpan M; Lemaire F; Mertens B; Dusinska M; Fessard V; Hoet PH
ALTEX; 2024 Jan; 41(1):76-90. PubMed ID: 37606097
[TBL] [Abstract][Full Text] [Related]
8. AOP-DB: A database resource for the exploration of Adverse Outcome Pathways through integrated association networks.
Pittman ME; Edwards SW; Ives C; Mortensen HM
Toxicol Appl Pharmacol; 2018 Mar; 343():71-83. PubMed ID: 29454060
[TBL] [Abstract][Full Text] [Related]
9. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
[TBL] [Abstract][Full Text] [Related]
10. Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity.
Zilliacus J; Draskau MK; Johansson HKL; Svingen T; Beronius A
Front Toxicol; 2024; 6():1357717. PubMed ID: 38601197
[No Abstract] [Full Text] [Related]
11. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network.
Tollefsen KE; Alonzo F; Beresford NA; Brede DA; Dufourcq-Sekatcheff E; Gilbin R; Horemans N; Hurem S; Laloi P; Maremonti E; Oughton D; Simon O; Song Y; Wood MD; Xie L; Frelon S
Int J Radiat Biol; 2022; 98(12):1816-1831. PubMed ID: 35976054
[TBL] [Abstract][Full Text] [Related]
12. Exploring a mechanism-based approach for the identification of endocrine disruptors using Adverse Outcome Pathways (AOPs) and New Approach Methodologies (NAMs) : A perfluorooctane sulfonic acid case study.
Wiklund L; Pípal M; Weiss J; Beronius A
Toxicology; 2024 May; 504():153794. PubMed ID: 38580097
[TBL] [Abstract][Full Text] [Related]
13. Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer.
Stainforth R; Schuemann J; McNamara AL; Wilkins RC; Chauhan V
Int J Radiat Biol; 2021; 97(1):85-101. PubMed ID: 32909875
[TBL] [Abstract][Full Text] [Related]
14. Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach.
van Ertvelde J; Verhoeven A; Maerten A; Cooreman A; Santos Rodrigues BD; Sanz-Serrano J; Mihajlovic M; Tripodi I; Teunis M; Jover R; Luechtefeld T; Vanhaecke T; Jiang J; Vinken M
J Biomed Inform; 2023 Sep; 145():104465. PubMed ID: 37541407
[TBL] [Abstract][Full Text] [Related]
15. Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.
Becker RA; Ankley GT; Edwards SW; Kennedy SW; Linkov I; Meek B; Sachana M; Segner H; Van Der Burg B; Villeneuve DL; Watanabe H; Barton-Maclaren TS
Regul Toxicol Pharmacol; 2015 Aug; 72(3):514-37. PubMed ID: 25863193
[TBL] [Abstract][Full Text] [Related]
16. sAOP: linking chemical stressors to adverse outcomes pathway networks.
Aguayo-Orozco A; Audouze K; Siggaard T; Barouki R; Brunak S; Taboureau O
Bioinformatics; 2019 Dec; 35(24):5391-5392. PubMed ID: 31329252
[TBL] [Abstract][Full Text] [Related]
17. Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge.
Pollesch NL; Villeneuve DL; O'Brien JM
Toxicol Sci; 2019 Apr; 168(2):349-364. PubMed ID: 30715536
[TBL] [Abstract][Full Text] [Related]
18. [Molecular Pathway and AOP Development Using Gene Network Analysis].
Tanabe S; Hirose A; Whelan M; Yamada T
Yakugaku Zasshi; 2020; 140(4):485-489. PubMed ID: 32238629
[TBL] [Abstract][Full Text] [Related]
19. AOP Report: Inhibition of Chitin Synthase 1 Leading to Increased Mortality in Arthropods.
Schmid S; Song Y; Tollefsen KE
Environ Toxicol Chem; 2021 Aug; 40(8):2112-2120. PubMed ID: 33818824
[TBL] [Abstract][Full Text] [Related]
20. A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation.
Svingen T; Villeneuve DL; Knapen D; Panagiotou EM; Draskau MK; Damdimopoulou P; O'Brien JM
Toxicol Sci; 2021 Nov; 184(2):183-190. PubMed ID: 34534351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
